Table 1.
Comparison of the demographic characteristics between severe and non-severe patients with COVID-19
| Demographic characteristics | All patients (n = 151) | Severe Group (n = 29, 19.2%) | Non-severe Group (n = 122, 80.8%) | P-value |
|---|---|---|---|---|
| Age (y), mean | 63 ± 14 | 72 ± 14 | 61 ± 13 | < 0.001 |
| < 65 | 80 (53.0) | 5 (17.2) | 75 (61.5) | < 0.001 |
| ≥ 65 | 71 (47.0) | 24 (82.8) | 47 (38.5) | |
| Gender | 0.475 | |||
| Male | 64 (42.4) | 14 (48.3) | 50 (41.0) | |
| Female | 87 (57.6) | 15 (51.7) | 72 (59.0) | |
| Clinical symptoms | ||||
| Cough | 103 (68.2) | 17 (58.6) | 86 (70.5) | 0.217 |
| Productive cough | 42 (27.8) | 6 (20.7) | 36 (29.5) | 0.341 |
| Fever | 101 (66.9) | 18 (62.1) | 83 (68.0) | 0.540 |
| Dyspnea | 29 (19.2) | 20 (69.0) | 9 (7.4) | < 0.001 |
| Fatigue | 106 (70.2) | 24 (82.8) | 82 (67.2) | 0.100 |
| Comorbidities | ||||
| Any | 85 (56.3) | 17 (58.6) | 68 (55.7) | 0.778 |
| COPD | 6 (4.0) | 1 (3.4) | 5 (4.1) | 1.000 |
| Hypertension | 60 (39.7) | 13 (44.8) | 47 (38.5) | 0.533 |
| Diabetes | 32 (21.2) | 9 (31.0) | 23 (18.9) | 0.149 |
| Cardiovascular disease | 18 (11.9) | 2 (6.9) | 16 (13.1) | 0.528 |
| Cancer | 5 (3.3) | 1 (3.4) | 4 (3.3) | 1.000 |
| Other chronic history | 6 (4.0) | 5 (17.2) | 1 (0.8) | 0.001 |
| Noneffective antibiotic treatment | 25 (16.6) | 10 (34.5) | 15 (12.3) | 0.010 |
Values are presented as mean ± standard deviation or number (%). COVID-19, coronavirus disease 2019; COPD chronic obstructive pulmonary disease